Please login to the form below

Not currently logged in
Email:
Password:

Kengreal

This page shows the latest Kengreal news and features for those working in and with pharma, biotech and healthcare.

FDA gives the nod to TMC's antiplatelet drug

FDA gives the nod to TMC's antiplatelet drug

FDA gives the nod to TMC's antiplatelet drug. Kengreal approved in the US three months after it got the green light in Europe. ... The Medicines Company (TMC) has finally won US approval for its injectable antiplatelet drug Kengreal for the prevention of

Latest news

More from news
Approximately 1 fully matching, plus 0 partially matching documents found.

Latest Intelligence

  • Deal Watch May 2016 Deal Watch May 2016

    911. The Medicines Company/ Chiesi. Product acquisition. Acquisition of cardiovascular assets Cleviprex, Kengreal and rights to Argatroban.

More from intelligence
Approximately 0 fully matching, plus 1 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
OUTiCO

Providing an exceptional outsourcing service to the Pharma & Healthcare industries. We offer a sustainable approach and drive sales outcomes...

Latest intelligence

The threat of antimicrobial resistance
Why this issue is such a fundamental challenge...
Meet the CEO behind ReNeuron’s cutting-edge stem cell therapies
Blue Latitude Health speaks to Olav Hellebo, CEO of ReNeuron, to find out about the biotech’s latest innovation in stem cell therapy and to learn his perspective on navigating the...
Unique forum will unite NHS and industry to drive innovation
HSJ Life Sciences Forum will explore key NHS challenges and debate future of medicines, by Sarah Eglington, Client Services Director at Wilmington Healthcare...

Infographics